This level sections

Top level sections

Site Links

Home | Directory | Companies

Enterprise Ireland Lifescience & Food Commercialisation Group (EI Bio)

Profile   Events   News

Enterprise Ireland's vision is to transform Irish companies into businesses that are market-focused and innovation-driven. Enterprise Ireland's Lifescience & Food Commercialisation Group (EI Bio) builds the lifescience and food sectors through the strategic commercialisation of research in Ireland. Enterprise Ireland provides expertise, funding and support to industry and to third-level educational institutions in Ireland. All our activities are driven by a common aim: to ensure that Ireland is a competitive, knowledge-based economy capable of sustainable growth. Competitive industry and high-quality research are the primary engines of growth and Enterprise Ireland provides the support necessary to continue making progress.

contact

The Plaza, East Point Business Park, Dublin 3, IRELAND (REPUBLIC)

Tel:+353 1 7272692

Fax:+353 1 727 2071

Email:

Web:http://www.enterprise-ireland.com

main contacts

Mr Declan McGee (Communication Manager )

Dr Liz Moran (Senior Technology Analyst - Commercialisation Specialist (RCSI, UL, ITB))

Dr Ruth McMahon (Commercialisation Specialist (UCD,IADT, ITTD))

Dr Keith O'Neill (Director)

Elizabeth Caplice (Senior Biotechnology Analyst, Commercialisation Specialist (UCC, WIT, CIT) )

Rosemary Durcan (Commercialisation Specialist (UCD, UCC))

Dr Niamh Keon (Senior Technology Analyst, Commercialisation Specialist (ITC))

Dr Noel Daly (Commercialisation Specialist (DCU, DIT, NUIM))

Dr Maura Glennon (Commercialisation Specialist (NUIG, GMIT) )

Dr James Walsh (Commercialisation Specialist (NUIG, UL, ITS, LYIT, LIT, AIT, ITT))

Dr Sean Mulvany (Commercialisation Specialist (TCD, DKIT))

Dr Christian Stafford (Commercialisation Specialist (UCC))

Dr Deirdre Leane (Commercialisation Specialist)

Ms Deirdre Glenn (Commercial Team Head)

Enterprise Ireland has six key action areas in our technology offer, each encompassing a wide range of activities. Whatever your industry sector or research focus, Enterprise Ireland can provide support tailored to your specific needs, within one or more of the following: 1 Productivity Improvement 2 R&D within Enterprise 3 R&D Collaboration 4 Research Commercialisation 5 International R&D Collaboration 6 Technology Acquisition COMMERCIALISING RESEARCH There are three Enterprise Ireland expert teams working with researchers who are interested in seeing their research work put to commercial use. These teams are focused on: Lifesciences & Food Industrial Technologies Informatics ENTERPRISE IRELAND LIFESCIENCE & FOOD TEAM The Enterprise Ireland Lifescience & Food Commercialisation Group (EI Bio) forms the crucial link in the commercialisation chain for research: connecting the researchers who conduct the research, and the entrepreneurs, industrialists and companies who apply the fruits of that research. EI Bio works in partnership with all its stakeholders and clients - industrial liaison and technology transfer offices, research funders, research institutions, research teams, bio-entrepreneurs and companies, and with Enterprise Ireland's other sectoral teams to commercialise the outputs of publicly-funded research for Ireland's food, health and life sciences sectors. EI Bio has strategic focus areas. Each area has a multi-disciplinary team made up of people skilled in the three core competencies of project/strategic management, the relevant technologies, and research commercialisation. COMMERCIAL AND TECHNICAL EXPERTISE So that EI Bio is best placed to commercialise the results of Irish biotech research, we have located some of our staff as close as possible to where the research happens. A number of our commercialisation specialists and project officers are embedded at selected campus Technology Transfer Offices. This allows us to build strong alliances with the research institutes and their technology transfer offices and to respond quickly to their needs. EI Bio commercialisation staff are assigned to Dublin City University, Trinity College Dublin, University College Cork, University College Dublin, National University of Ireland, Galway the University of Limerick and the Royal College of Surgeons in Ireland. EI Bio also continues to forge strong new relationships with other campuses involved in lifesciences & food. Commercialisation Fund EI Bio promotes participation in the Enterprise Ireland Commercialisation Fund. The fund consists of 3 elements: The Proof of Concept Fund; The Technology Development Fund and The Business Development Fund. Funding is open to researchers in all institutes and colleges and it is available to researchers with whom EI has not interacted before as well as those who have been successful in previous funding schemes. BioIncubation Enterprise Ireland has provided financial support for the conversion of six existing buildings into bioincubators which will provide laboratory and office space for up to twenty start-up companies. The facilities are located at Dublin City University, NUI Galway, St. James's Hospital, Trinity College Dublin, University College Cork and University College Dublin. The facilities are available to a range of clients including University spin-outs, company spin-outs, entrepreneurs from overseas, ex-patriate entrepreneurs and for foreign companies who wish to relocate to Ireland. The bioincubators provide professional research and commercialisation services, access to financial, legal and marketing advice and help for start-up companies to establish themselves. Bioindustry-Led Research Networks EI Bio and the Irish bioindustry sector have embarked on a consultative process to identify opportunities for bioindustry-led academic research. An Advisory Board has been formed and a BioIndustry Led Network has been established. The network comprises wide representation from industry and academia and is endorsed by the Irish BioIndustry Association (IBIA). The aim of this pilot project is to stimulate bioindustry-relevant research in Irish universities and research institutes. An initial six-month phase of the project involves feasibility studies being carried out by multidisciplinary, cross-institutional teams on the following broad themes: improved sensitivity and quantitation for rapid binding assays for Point of Care (POC) applications and in-line and at-line bioprocess monitoring Seven academic Institutes (UCC, UCD, NDC, NUIM, NUIG, Tyndall Institute and UL) are co-operating on these two projects bringing together their skills and expertise in areas such as microfluidics, sensor development, biomaterials and bio-assay development to address the needs of Irish bioindustry. This project is the first of its kind in the Irish sector and the unique combination of academic and industrial partners provides a model that is very well placed to address the needs of the sector. It is proposed that following from this initial feasibility stage of the project, the project teams will proceed to Phase 2 which would involve two-year projects in these areas. Communications EI Bio runs the www.biotechnologyireland.com portal and publishes the Irish Biotech News magazine. We also run technology showcase events, regulatory affairs and patenting and licensing workshops. EI Bio also supports the activities of a number of networks in the lifesciences area. CONTACTS ENTERPRISE IRELAND'S LIFESCIENCE & FOOD COMMERCIALISATION GROUP (EI Bio) Dr Keith O'Neill, Director Email: keith.oneill@enterprise-ireland.com Tel: +353 1 8082462 For general enquiries contact: Email: biotech.direct@enterprise-ireland.com Tel: +353 1 8370177 WWW.ENTERPRISE-IRELAND.COM WWW.BIOTECHNOLOGYIRELAND.COM

Key: Academic\Public Research, Pharmaceutical, Technology Transfer, Biotech\Bioscience, Government, Patent\Licensing\Legal, Republic of Ireland

Copyright Biotechnology Ireland 2010